Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-11

Clinical Trial Update: In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases [NA]

View source ↗

Summary

A completed clinical trial update reporting an in vitro study of interleukin-2 muteins on regulatory T cells in patients with autoimmune, allo-immune, or inflam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interleukin-2 muteins (interleukin-2 mutein)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Autoimmune Diseases, Inflammatory Disease | NA | Status: COMPLETED